David Hui Li serves as Executive at China Biologic Products, Inc., where they oversee executive responsibilities. Since joining the company, David Hui Li has executed 6 insider transactions totaling $265.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 11, 2016 involved receiving (via award) 269 shares valued at $0.
David Hui Li currently holds 269 shares of China Biologic Products, Inc. (CBPO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Hui Li has been a net seller of CBPO stock. They have purchased $0 and sold $265.2M worth of shares.
David Hui Li's most recent insider trade was on Aug 11, 2016, when they sold 269 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2016 | CBPO | $0 | Award | 15,000 | $N/A | Discretionary |
| Feb 22, 2016 | CBPO | $0 | Award | 5,000 | $N/A | Discretionary |
| Feb 22, 2016 | CBPO | $0 | Award | 5,000 | $N/A | Discretionary |
| Jun 15, 2015 | CBPO | $265.2M | Sale | 2,645,000 | $100.28 | Discretionary |